EMA Authorised: Voxzogo (vosoritide) — BioMarin International Limited

View source ↗

Summary

The European Medicines Agency authorised Voxzogo (vosoritide) for the treatment of achondroplasia. The Marketing Authorisation Holder is BioMarin International …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Achondroplasia

Drugs mentioned

• VOXZOGO (VOSORITIDE)

Snippet

Status: Authorised. Therapeutic area: Achondroplasia. MAH: BioMarin International Limited. Decision date: 17/11/2025. Orphan medicine